HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lymphoma with bone marrow infiltration undergoing peripheral blood progenitor cell transplantation.

AbstractBACKGROUND AND OBJECTIVES:
IgH gene rearrangement studies with a polymerase chain reaction (PCR) technique can detect the persistence of clonal cells at molecular level during the remission phase. This persistence of clonal cells can be used to establish the relationship between minimal residual disease (MRD) and clinical outcome. We have developed a three-step single strand conformational polymorphism PCR strategy which is able to detect clonal B lymphoid cells at a frequency as low as 1 clonal cell in 10(6) normal cells.
DESIGN AND METHODS:
Twenty patients with intermediate or high-grade B non-Hodgkin's lymphoma (NHL) were evaluated. Patients were pre-treated with a median of two (range 1-4) conventional chemotherapy lines before high-dose cyclophosphamide (HDCY). All patients had their bone marrow (BM) involved by disease (median 10%; range 5-50%). Nineteen patients were offered high-dose therapy followed by peripheral blood progenitor cells (PBPC) autografting.
RESULTS:
MRD analysis was performed for each patient at the end of conventional chemotherapy and every three months after high dose therapy. All these patients achieved complete response (CR) after high dose therapy (HDT). Six patients relapsed after a median time of 24.5 months. All the studied apheresis samples were positive at the molecular analysis. All 6 patients still positive at the molecular analysis after PBPC autografting relapsed. The remaining 13 patients who were negative maintained CR.
INTERPRETATION AND CONCLUSIONS:
Whereas the detection of clonal cells in the apheresis samples did not predict an unfavorable outcome, the disappearance of the clonal rearranged band from the BM sample after HDT proved to be a favorable prognostic factor and was associated with long-lasting disease-free status
AuthorsM Miglino, G Santini, R Grasso, D Pietrasanta, M Clavio, I Pierri, L Canepa, S Nati, F Ballerini, R Varaldo, G Palmisano, M Gobbi
JournalHaematologica (Haematologica) Vol. 86 Issue 7 Pg. 706-14 (Jul 2001) ISSN: 0390-6078 [Print] Italy
PMID11454525 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunoglobulin Heavy Chains
Topics
  • Adult
  • Bone Marrow (pathology)
  • Female
  • Gene Rearrangement
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Immunoglobulin Heavy Chains (genetics)
  • Lymphoma, B-Cell (diagnosis, pathology, therapy)
  • Male
  • Middle Aged
  • Neoplasm Invasiveness (pathology)
  • Neoplasm, Residual (diagnosis, genetics, pathology)
  • Prognosis
  • Prospective Studies
  • Recurrence
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: